INSIGHTS ON CLINICAL TRIAL DESIGN
-
![Scout image]( "Hey There. We're Scout")
Hey There. We're ScoutLearn how clear workflows, proactive support, and accessible technology help translate services into real participant retention.
-
![Artificial intelligence-macine learning-GettyImages-1368016158]( "How AI Is Reshaping Trial Design, Execution, And Disclosure")
How AI Is Reshaping Trial Design, Execution, And DisclosureAI has quietly embedded itself into the operational heart of clinical development, where it is accelerating decisions, reducing manual burden, and improving outcomes.
-
![GettyImages-1903424167-medical-meeting-clinical-setting-doctors]( "Why Early Phase Speed Depends On Oncology Expertise")
Why Early Phase Speed Depends On Oncology ExpertiseEarly phase oncology speed depends on confident, oncology‑specific decisions made upfront. Learn why scientific expertise, realistic planning, and foresight determine whether programs maintain momentum.
-
![brain-scan-GettyImages-2160716915]( "Leading Recruitment With A Strong Alzheimer's Referral Pool")
Leading Recruitment With A Strong Alzheimer's Referral PoolA strong referral network helped the Gainesville site rapidly recruit pTau217‑positive Alzheimer’s participants while upholding high data quality, boosting enrollment and outperforming other sites.
-
Clinical Trial Access In The U.S.: Where Are Today's Trials Missing?7/9/2024
Access to clinical trials in the U.S. is uneven, leaving many regions underserved. Let's examine site distribution, the impact of healthcare deserts, and ways to improve trial accessibility for all Americans.
-
The Scoop On The SCOPE Summit2/19/2025
From industry partnerships to patient recruitment to proprietary data, SCOPE 2025 was packed with informational sessions.
-
Linking Neurology And Ophthalmology For Clinical Trials1/22/2025
Learn more about the innovative approach being taken to incorporate ophthalmology into neurology and central nervous system (CNS) research.
-
Patient Trust And Engagement In The Age Of Decentralized Trials4/10/2025
To truly maximize enrollment in decentralized models, sponsors must invest in human connection to build the trust needed to move patients from awareness to active participation.
-
Lack Of IRT/RTSM System Reusability Surprises Every Clinical Trial Sponsor2/26/2026
Stop re-learning your IRT system with every new trial. Uncover why "standard" features often hide custom complexities that slow down UAT and clinical operations.
CLINICAL TRIAL DESIGN SOLUTIONS
-
When considering clinical trial disclosure solutions, it is important to understand the potential partner’s practical experience and how their solution fits your compliance needs today and in the future.
-
![GettyImages-638646884 medical team meeting]( "Rethinking Lab Logistics: Delivering The Complex Without Compromise")
Through Home Trial Support (HTS), it is possible to carry out even the most demanding sampling protocols safely, consistently, and at scale—bringing collection and processing directly to patients.
-
![New Anti-Cancer Drug Shows Promising Results With Low Toxicity]( "Bold Thinking Overcomes Oncology Clinical Development Challenges")
Veristat ensures that your clinical trial or program design supports your regulatory strategy, whether you plan to run a single pivotal trial or multiple trials.
-
![rtsm-clinical-trial-tech-GettyImages-872024272]( "PULSE: Empowering Every Phase of Your Clinical Journey")
A flexible RTSM platform improves study startup, real‑time design updates, oversight, and global supply management, enabling faster execution, clearer visibility, and streamlined trial operations.
-
![GettyImages-1275317360-lab-cell-gene-research-scientist-development-discovery]( "Central Nervous System Drug Development")
CNS drug development faces unique hurdles — from high placebo response to complex protocols and recruitment challenges. Discover strategies to streamline trials, optimize planning, and accelerate delivery of innovative therapies for patients with critical unmet needs.
